Abstract
Background Obstructive sleep apnea (OSA) is a chronic sleep disorder with a continuously growing prevalence. Over 1 billion individuals across the globe experience some form of sleep apnea, and this number is steadily rising. OSA can negatively influence one’s quality of life (QOL), while also increasing their risk for mortality from many causes. However, this association between OSA and mortality has not been comprehensively and thoroughly explored. This meta-analysis was conducted to conclusively estimate the risk of death for all-cause mortality and cardiovascular mortality in OSA patients.
Study Design 4,613 articles from databases including PUBMED, OVID & Joana Briggs, and SCOPUS were comprehensively assessed by two reviewers (AES & ESH) for inclusion criteria. 28 total articles were included, with 22 of them being used for quantitative analysis. Pooled effects of all-cause mortality, cardiac mortality, and sudden death were calculated by utilizing the metaprop function in R Statistical Software and the random-effects model with appropriate 95% confidence intervals.
Results The 22 included articles utilized for quantitative analysis contained 42,032 participants. The pooled HR for all-cause mortality was 1.74 (95%CI 1.40-2.10). Cardiac mortality had a pooled HR of 1.94 (95%CI 1.39-2.70). These results illustrate that individuals with obstructive sleep apnea have almost twice the risk for both cardiac mortality and all-cause mortality in comparison to the general population.
Conclusions Individuals with obstructive sleep apnea are at an increased risk for all-cause mortality and cardiac mortality. Further research related to appropriate interventions and treatments are necessary in order to reduce this risk and optimize survival in this population.
Funding This Study was not funded
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
N/A
Funding Statement
No funding
Author Declarations
All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.
Yes
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data is available within table 1 and the figures